The U.S. Court of Appeals for the Second Circuit on Thursday upheld the convictions of two former executives who engineered a secret kickback scheme to defraud drugmaker Valeant Pharmaceuticals International.

A three-judge panel of the Manhattan-based appeals court said there was “ample evidence” to support the 2018 convictions of Gary Tanner, the ex-Valeant executive, and former Philidor Rx Services CEO Andrew Davenport on four charges, including fraud and conspiracy to commit money laundering.